DeepMed Research

UNIVERSITY OF CALIFORNIA, DAVIS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1905-01-01

Employees: 10K

Market Cap: -

Website: http://www.ucdavis.edu

Clinical Trials

Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan

Phase 2

Completed

Conditions: Hematologic Malignancies

First Posted Date: 2009-02-13

Last Posted Date: 2017-06-27

Lead Sponsor: University of California, Davis

Target Recruit Count: 8

Registration Number: NCT00843947

Locations: 🇺🇸
University of CA, Davis Cancer Center, Sacramento, California, United States

Comparison of Video-Based Versus Written Patient Education on Melanoma

Not Applicable

Completed

Conditions: Melanoma
Malignant Melanoma

Interventions: Other: Patient Educational Materials

First Posted Date: 2009-01-22

Last Posted Date: 2015-04-22

Lead Sponsor: University of California, Davis

Target Recruit Count: 78

Registration Number: NCT00826995

Locations: 🇺🇸
University of California Davis Department of Dermatology, Sacramento, California, United States

Comparison Of Video-based Versus Written Patient Education on Sunscreen

Not Applicable

Completed

Conditions: Skin Cancer
Dermatology Disease

Interventions: Other: Patient Educational Materials

First Posted Date: 2009-01-22

Last Posted Date: 2015-04-16

Lead Sponsor: University of California, Davis

Target Recruit Count: 94

Registration Number: NCT00826306

Locations: 🇺🇸
University of California Davis Department of Dermatology, Sacramento, California, United States

Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis

Not Applicable

Completed

Conditions: Hand Eczema
Atopic Dermatitis
Atopic Eczema
Infantile Eczema

Interventions: Other: Patient Educational Materials

First Posted Date: 2009-01-22

Last Posted Date: 2015-04-16

Lead Sponsor: University of California, Davis

Target Recruit Count: 80

Registration Number: NCT00826592

Locations: 🇺🇸
University of California Davis Department of Dermatology, Sacramento, California, United States

Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Bicalutamide
Drug: Everolimus

First Posted Date: 2008-12-25

Last Posted Date: 2018-01-10

Lead Sponsor: University of California, Davis

Target Recruit Count: 24

Registration Number: NCT00814788

Locations: 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States

Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: Erlotinib
Drug: gemcitabine

First Posted Date: 2008-12-18

Last Posted Date: 2018-01-10

Lead Sponsor: University of California, Davis

Target Recruit Count: 30

Registration Number: NCT00810719

Locations: 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States
🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States

Sorafenib in Treating Patients With Advanced Malignant Solid Tumors

Phase 2

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: Sorafenib

First Posted Date: 2008-12-18

Last Posted Date: 2018-01-10

Lead Sponsor: University of California, Davis

Target Recruit Count: 50

Registration Number: NCT00810394

Locations: 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States

The Impact of Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Premature Infants

Phase 1

Completed

Conditions: Fecal Microflora in the Formula Fed Premature Infant

Interventions: Dietary Supplement: Bifidobacterium infantis
Dietary Supplement: ProlactPlus
Dietary Supplement: GOS galacto-oligosaccharides
Dietary Supplement: Bifidobacterium animalis

First Posted Date: 2008-12-17

Last Posted Date: 2017-07-13

Lead Sponsor: University of California, Davis

Target Recruit Count: 59

Registration Number: NCT00810160

Locations: 🇺🇸
UC Davis Medical Center, Sacramento, California, United States

Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors

Phase 1

Terminated

Conditions: Lung Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: Carboplatin
Drug: Etoposide
Drug: RAD001

First Posted Date: 2008-12-12

Last Posted Date: 2018-01-09

Lead Sponsor: University of California, Davis

Target Recruit Count: 5

Registration Number: NCT00807755

Locations: 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States

Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors

Phase 1

Terminated

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: ixabepilone
Drug: lapatinib ditosylate

First Posted Date: 2008-12-08

Last Posted Date: 2012-03-28

Lead Sponsor: University of California, Davis

Target Recruit Count: 5

Registration Number: NCT00804310

Locations: 🇺🇸
Feist-Weiller Cancer Center at Louisiana State University Health Sciences, Shreveport, Louisiana, United States
🇺🇸
City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy